These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34885967)
1. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design. Yu W; Wu X; Zhao Y; Chen C; Yang Z; Zhang X; Ren J; Wang Y; Wu C; Li C; Chen R; Wang X; Zheng W; Liao H; Yuan X Molecules; 2021 Dec; 26(23):. PubMed ID: 34885967 [TBL] [Abstract][Full Text] [Related]
2. Depicting the inhibitory potential of polyphenols from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085 [TBL] [Abstract][Full Text] [Related]
3. Deciphering inhibitory activity of marine algae Ecklonia cava phlorotannins against SARS CoV-2 main protease: A coupled in-silico docking and molecular dynamics simulation study. Chakraborty A; Ghosh R; Barik S; Mohapatra SS; Biswas A; Chowdhuri S Gene; 2024 Oct; 926():148620. PubMed ID: 38821329 [TBL] [Abstract][Full Text] [Related]
4. Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease. Ngo ST; Quynh Anh Pham N; Thi Le L; Pham DH; Vu VV J Chem Inf Model; 2020 Dec; 60(12):5771-5780. PubMed ID: 32530282 [TBL] [Abstract][Full Text] [Related]
5. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective. Chakraborty A; Ghosh R; Soumya Mohapatra S; Barik S; Biswas A; Chowdhuri S Gene; 2024 Sep; 922():148553. PubMed ID: 38734190 [TBL] [Abstract][Full Text] [Related]
6. Identification of polyphenols from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411 [TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study. Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Mar; 40(5):2053-2066. PubMed ID: 33094701 [TBL] [Abstract][Full Text] [Related]
8. Biflavonoids from Lokhande K; Nawani N; K Venkateswara S; Pawar S J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613 [TBL] [Abstract][Full Text] [Related]
10. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429 [TBL] [Abstract][Full Text] [Related]
11. Insight into crystal structures and identification of potential styrylthieno[2,3- El Bakri Y; Ahmad B; Saravanan K; Ahmad I; Bakhite EA; Younis O; Al-Waleedy SAH; Ibrahim OF; Nafady A; Mague JT; Mohamed SK J Biomol Struct Dyn; 2024 May; 42(8):4325-4343. PubMed ID: 37318002 [TBL] [Abstract][Full Text] [Related]
12. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Apr; 40(6):2647-2662. PubMed ID: 33140695 [TBL] [Abstract][Full Text] [Related]
13. Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations. Handa Y; Okuwaki K; Kawashima Y; Hatada R; Mochizuki Y; Komeiji Y; Tanaka S; Furuishi T; Yonemochi E; Honma T; Fukuzawa K J Phys Chem B; 2024 Mar; 128(10):2249-2265. PubMed ID: 38437183 [TBL] [Abstract][Full Text] [Related]
14. Identification of alkaloids from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Mol Struct; 2021 Apr; 1229():129489. PubMed ID: 33100380 [TBL] [Abstract][Full Text] [Related]
15. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698 [TBL] [Abstract][Full Text] [Related]
16. In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease. de Oliveira Só YA; Bezerra KS; Gargano R; Mendonça FLL; Souto JT; Fulco UL; Pereira Junior ML; Junior LAR Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062468 [TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro. Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056 [TBL] [Abstract][Full Text] [Related]
19. Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L. Costanzi E; Kuzikov M; Esposito F; Albani S; Demitri N; Giabbai B; Camasta M; Tramontano E; Rossetti G; Zaliani A; Storici P Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769210 [TBL] [Abstract][Full Text] [Related]
20. Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents. Zagórska A; Czopek A; Fryc M; Jończyk J Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]